Breast Cancer
Randomized, Open-Label Study of the BRIA-IMT Regimen and Check Point Inhibitor vs Physician's Choice in Advanced Metastatic Breast Cancer. (BRIA-ABC) (BC-IMT-04)
- Details
ClinicalTrials.gov ID:
NCT06072612
Diagnosis Type:
NA
USOR Number:
- Address
,
P: